Stock index futures were lower on Monday as investors looked forward to Big Tech earnings slated to come in this week and ...
Zacks Investment Research on MSN
Countdown to Lilly (LLY) Q1 earnings: Wall Street forecasts for key metrics
The upcoming report from Eli Lilly (LLY) is expected to reveal quarterly earnings of $7.26 per share, indicating an increase of 117.4% compared to the year-ago period. Analysts forecast revenues of ...
Eli Lilly shares sink as data shows Foundayo trailing Novo’s oral Wegovy. But there’s reason to consider buying LLY shares on ...
Eli Lilly (LLY) acquires Ajax Therapeutics for $2.3B, adding AJ1-11095, a novel JAK2 inhibitor for myelofibrosis and blood ...
By Christy Santhosh April 27 (Reuters) - Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax ...
Can Eli Lilly (NYSE: LLY) stock surge 2x to $2,000 in the coming years? We believe that this is indeed a genuine possibility.
On April 20, Reuters reported that Eli Lilly and Company (NYSE:LLY) is buying Kelonia Therapeutics in a deal valued at up to ...
Eli Lilly and Company (NYSE:LLY) is one of the 8 Best Beginner Stocks to Buy Right Now. On April 15, 2026, Eli Lilly and ...
Eli Lilly (LLY) stock fell 2% as Foundayo recorded 3,707 week-two prescriptions, significantly trailing Novo Nordisk's oral ...
Eli Lilly and Company (NYSE:LLY) is one of the best low volatility stocks to invest in right now. On April 24, Reuters ...
Eli Lilly (LLY) stock slips as IQVIA data show that the company's obesity drugs Zepbound and Foundayo lag Novo’s (NVO) Wegovy ...
The fund, under normal market conditions, will invest at least 80% of its net assets (plus any borrowings for investment purposes) in shares of LLY, investments that provide exposure to LLY or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results